Cargando…
Tocilizumab: Decrease in WBC count following an off-label use: case report
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7677435/ http://dx.doi.org/10.1007/s40278-020-86526-4 |
Ejemplares similares
-
Favipiravir/tocilizumab: Increased lymphocyte count and transaminases following off-label use: 4 case reports
Publicado: (2021) -
Tocilizumab: Anaphylaxis following off-label use: case report
Publicado: (2021) -
Tocilizumab: Neutropenia following off-label use: case report
Publicado: (2021) -
Methylprednisolone: Decrease in T cell count following off label use: case report
Publicado: (2020) -
Tocilizumab: Septic shock following off-label use: case report
Publicado: (2020)